22.28
輸血は、命を救い、さまざまな病状を治療する重要な医療処置です。これには、ドナーからレシピエントへの血液の移送が含まれます。このプロセスには、ABO式血液型システムとそれに関連する抗原および抗体を完全に理解する必要があります。
輸血の概要
輸血は、怪我や手術によって失われた血液を補充するため、または貧…
輸血は、怪我、手術、または貧血や癌などの状態の治療によって失われた全血またはその成分を置き換える医療処置です。
輸血を成功させるためには、ドナーとレシピエントの血液が抗原抗体反応を避けるために互換性がある必要があります。
この適合性は、通常、ABO式血液型システムを使用して決定されます。
例えば、A型の患者がB型のドナーから血液を受け取ると、レシピエントの抗B抗体がドナーの細胞上のB抗原と反応し、凝集と溶血を引き起こします。
O型の血液を持つ人は、A抗原またはB抗原を欠いているため、理論的にはO型血液型は普遍的なドナーグループになります。
逆に、AB型の血液型の人は、A抗原またはB抗原に対する抗体がないため、普遍的なレシピエントと見なされます。
しかし、ABOシステムに基づくユニバーサルレシピエントおよびドナーの臨床応用は、RhファミリーのようなABO抗原以外の他の天然に存在する抗原のためにリスクを伴う可能性があります。
したがって、輸血の合併症を避けるためには、正確に一致した血液型を使用するのが最善です。
View the full transcript and gain access to JoVE Core videos
Q1: Why is blood type compatibility important for transfusions?
Blood type compatibility prevents dangerous antigen-antibody reactions. If a recipient receives incompatible blood, their antibodies attack the donor's red blood cells, causing agglutination and hemolysis. For example, a type A patient receiving type B blood triggers anti-B antibodies to react with B antigens on donor cells. Matching blood types ensures safe transfusion and protects patient health.
Q2: What makes type O blood a universal donor?
Type O blood lacks both A and B antigens on red blood cell surfaces. Since these antigens are absent, type O blood does not trigger antibody reactions in any recipient's bloodstream, regardless of their blood type. This absence of major ABO antigens makes type O the universal donor, though screening for other blood group systems remains important for safe transfusion.
Q3: How do AB blood type individuals serve as universal recipients?
Individuals with AB blood type lack antibodies against A and B antigens. Since they produce neither anti-A nor anti-B antibodies, their immune system does not attack donor red blood cells carrying these antigens. This allows AB recipients to safely receive blood from any ABO blood type without antibody-mediated agglutination or hemolysis.
Q4: What happens when agglutination occurs during a transfusion?
Agglutination is the clumping of red blood cells that occurs when a recipient's antibodies bind to incompatible donor antigens. This clumping can block blood vessels and trigger hemolysis, where red blood cells rupture and release hemoglobin into the bloodstream. Agglutination represents a serious transfusion reaction that can cause organ damage and life-threatening complications if incompatible blood is transfused.
Q5: Why is screening necessary beyond the ABO blood group system?
Although the ABO system classifies blood types, other naturally occurring antigens exist beyond A and B, such as the Rh family. Relying solely on universal donor and recipient concepts based on ABO can be risky because these other blood group systems may cause incompatibility reactions. Medical professionals conduct screening using soluble ABO antigens in bodily fluids or peripheral blood samples to identify all potential incompatibilities and prevent serious adverse reactions.
Q6: What medical conditions require blood transfusions?
Blood transfusions replace blood lost due to injury or surgery and treat conditions like anemia and cancer. Anemia reduces oxygen-carrying capacity, while cancer treatments may damage bone marrow's ability to produce red blood cells. Transfusions restore blood volume and oxygen delivery to tissues, supporting recovery and improving patient outcomes in these critical medical situations.
Q7: How does the ABO system classify blood types?
The ABO system classifies blood into four types based on the presence or absence of A and B antigens on red blood cell surfaces. Type A has A antigens, type B has B antigens, type AB has both, and type O has neither. Each blood type also produces specific antibodies: type A produces anti-B antibodies, type B produces anti-A antibodies, type AB produces neither, and type O produces both anti-A and anti-B antibodies.